KYMR short interest
Kymera Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 9,910,014 |
|---|---|
| Change vs prior report | -620,795 (-5.9%) |
| Change over six months | -4.7% |
| Days to cover | 11.97 (sector: 3.78) |
| Average daily volume | 828,028 |
| Rank in Healthcare | #70 of 922 by days to cover |
KYMR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 9,910,014 | -5.9% | 11.97 | 828,028 |
| 2026-09-15 | 10,530,809 | +1.5% | 16.13 | 652,859 |
| 2026-08-31 | 10,371,554 | -0.1% | 16.83 | 616,319 |
| 2026-08-14 | 10,382,744 | +4.1% | 13.94 | 744,554 |
| 2026-07-31 | 9,976,794 | +0.8% | 18.07 | 552,036 |
| 2026-07-15 | 9,900,469 | -2.4% | 14.67 | 674,870 |
| 2026-06-30 | 10,146,003 | +1.8% | 5.29 | 1,918,741 |
| 2026-06-15 | 9,962,823 | -1.4% | 15.59 | 639,045 |
| 2026-05-29 | 10,103,698 | +1.0% | 20.59 | 490,785 |
| 2026-05-15 | 10,004,363 | +3.3% | 21.29 | 469,885 |
| 2026-04-30 | 9,687,598 | +0.7% | 18.84 | 514,172 |
| 2026-04-15 | 9,622,452 | -7.5% | 19.48 | 493,999 |
| 2026-03-31 | 10,402,722 | +4.3% | 14.57 | 713,898 |
| 2026-03-13 | 9,968,655 | -3.0% | 13.82 | 721,531 |
| 2026-02-27 | 10,275,249 | +4.8% | 12.64 | 812,763 |
| 2026-02-13 | 9,807,318 | +4.8% | 11.92 | 823,029 |
| 2026-01-30 | 9,356,012 | +8.1% | 13.03 | 718,065 |
| 2026-01-15 | 8,651,616 | +9.0% | 11.69 | 740,128 |
| 2025-12-31 | 7,938,651 | +0.6% | 9.96 | 796,795 |
| 2025-12-15 | 7,894,340 | -9.1% | 4.12 | 1,917,469 |
| 2025-11-28 | 8,686,394 | +1.2% | 13.93 | 623,660 |
| 2025-11-14 | 8,581,283 | +6.7% | 10.06 | 853,352 |
| 2025-10-31 | 8,045,538 | -0.9% | 13.58 | 592,505 |
| 2025-10-15 | 8,118,708 | +0.4% | 12.14 | 668,552 |
| 2025-09-30 | 8,085,396 | +8.4% | 7.21 | 1,121,509 |
import finzdata as yf
yf.Ticker("KYMR").short_interest # every report since 2017
yf.Client().short_interest(["KYMR"], start="2018-01-01")Healthcare short interest · KYMR price history · Who owns KYMR · All short interest